The effects of a herbal combination on menopausal symptomatology

RMIT University (Australia)0 个研究点目标入组 103 人开始时间: 2006年8月17日最近更新: 2015年1月13日

适应症

试验速览

暂无简介。

•1. All participants must be women aged between 40 and 60 years
•2. Amenorrhoeic for 12 months or more or at least three months’ amenorrhoea in the past 12 months
•3. A minimum of five flushes (including sweating episodes) per 24 hour period
•4. A minimum score of 20 on the Greene Climacteric scale
•5. Prospective participants are required to obtain a general medical examination from a general practitioner

•1. Women on other concomitant treatment for menopausal symptoms, any formula containing the trial herbs, or any medication known to interact with either herb
•2. Women with any major health condition (such as history of epilepsy or seizures
•3. Pre-existing cancer, renal or liver disease, diabetes mellitus requiring treatment, uncontrolled hypertension
•4. Bipolar disorder, severe depression, current major psychiatric disorder, history of mania)
•5. Substance abuse
•6. Medically or surgically induced menopause
•7. Spasmodic dysmenorrhoea not associated with Pre-Menstrual Syndrome (PMS)
•8. Undiagnosed vaginal bleeding (in post-menopausal women)
•9. Known photosensitivity
•10. Known intolerance to St Johns Wort (Hypericum perforatum) or Chaste tree/berry (Vitex agnus-castus)
•11. Pregnancy or attempting to conceive
•12. Women participating in another clinical trial

发起方

RMIT University (Australia)